Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

MediWound's MW-005 studied in clinical trials for BCC and nonmelanoma skin cancers

July 26, 2021

Multiple kinase inhibitors identified at Medshine Discovery

July 26, 2021

Sunshine Lake Pharma, Dongguan Hec New Drug Research and Development patent RORgammaT antagonists

July 26, 2021

ECM1a isoform plays a tumorigenic role and confers cancer cell cisplatin resistance

July 26, 2021

TAE Life Sciences nominates product candidates for use with BNCT

July 23, 2021

CFT-2718 shows promising tumor growth reduction in models of SCLC

July 23, 2021

Pacylex recruits patients with solid malignancies and B-cell lymphoma in phase I trial of PCLX-001

July 23, 2021

Memorial Sloan Kettering Cancer Center presents new ULK1 inhibitors

July 23, 2021

Amplia reports phase I data on AMP-945

July 22, 2021

Tyra Biosciences presents new FGFR inhibitors

July 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...